TetraLogic Pharmaceuticals' Series C Round

TetraLogic Pharmaceuticals raised a round of funding on September 06, 2010.

TetraLogic Pharmaceuticals is focused on the discovery and development of drugs to treat cancer through technology which allows drugs to be developed that unblock the cell death or apoptosis pathway, …

Articles about TetraLogic Pharmaceuticals' Series C Round: